Page last updated: 2024-10-23

5-methoxypsoralen and Multiple Myeloma

5-methoxypsoralen has been researched along with Multiple Myeloma in 1 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bartnik, M1
Sławińska-Brych, A1
Mizerska-Kowalska, M1
Zdzisińska, B1

Other Studies

1 other study available for 5-methoxypsoralen and Multiple Myeloma

ArticleYear
Evaluation of the Biological Effect of Non-UV-Activated Bergapten on Selected Human Tumor Cells and the Insight into the Molecular Mechanism of Its Action.
    International journal of molecular sciences, 2023, Oct-25, Volume: 24, Issue:21

    Topics: 5-Methoxypsoralen; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Multiple

2023